Deal Library / Pharma BD Deal Intelligence

Lonza Group AG — Pharma Deals

The Pharma Closeout tracks 3 deals, $11.5B in disclosed deal value, 3 with a post-close Outcome Score for Lonza Group AG.

Median Critic Score: 88  ·  Median Outcome Score: 44

Best outcome: Lonza Group AG / Cambrex Bioproducts and Biopharma businesses (83)  ·  Weakest outcome: Lonza Group AG / Capsugel S.A. (KKR portfolio) (39)

All 3 deals

• Lonza Group AG / Cambrex Bioproducts and Biopharma businesses — 2006 · $460M · Worked — the deal delivered on its rationale.
• Lonza Group AG / Capsugel S.A. — 2016 · $5.5B · Underwhelmed — fell short of the thesis.
• Lonza Group AG / Capsugel S.A. (KKR portfolio) — 2016 · $5.5B · Underwhelmed — fell short of the thesis.

← Deal Library  ·  Interactive search  ·  How we score deals